New Cochlear CEO appointed
26 May, 2015Chris Smith has been announced as the incoming CEO and president of Cochlear Limited (ASX:COH). He will become the company's deputy CEO from 1 July and relocate to Sydney to take up the CEO position as of 1 September.
GSK granted $1 million for advanced manufacturing project
21 May, 2015Healthcare company GSK Australia has received a $1 million grant through the federal government's Manufacturing Transition Programme. The funding will support GSK's advanced manufacturing expansion plans at its Boronia site in Melbourne's outer-eastern suburbs.
Reformulation required for Phosphagenics pain patch
14 May, 2015 by Lauren DavisIt's been a less-than-ideal week for drug delivery company Phosphagenics (ASX:POH), which will soon be reformulating its TPM/Oxymorphone patch and beginning the search for a new chairman.
Europe agrees to blow the green whistle
09 May, 2015 by Lauren DavisThe Australian-invented painkiller Penthrox - commonly known as the 'green whistle' - has received initial regulatory approval for sale in the UK and Europe.
Drawbridge anaesthetic trial accepted for publication
07 May, 2015 by Lauren DavisDrawbridge Pharmaceuticals has announced the imminent publication of its phase 1c proof-of-concept clinical trial of Phaxan, a fast onset and offset intravenous general anaesthetic and sedative, in the medical journal Anesthesia and Analgesia.
2014 a good year for licensing transactions, says MoFo
04 May, 2015Law firm Morrison & Foerster's latest BioMeter report, recapping upfront licensing transactions among life sciences companies for all of 2014, confirms strong industry momentum which is said to be continuing into the current year.
$200 million for Medical Research Commercialisation Fund
21 April, 2015Brandon Capital Partners, the manager of the Medical Research Commercialisation Fund (MRCF), has announced the closing of a $200 million life science venture capital fund - Australia's largest ever life science venture fund.
Pain trial dosing and new directors at Phosphagenics
18 April, 2015Phosphagenics has commenced dosing in a phase 2 clinical trial investigating the safety and efficacy of the drug delivery company's TPM/oxycodone patch in patients suffering post-herpetic neuralgia (PHN), a complication of shingles.
Adam Kelliher announced as Avita Medical CEO
14 April, 2015Regenerative medicine company Avita Medical (ASX:AVH) has announced entrepreneur Adam Kelliher as its new chief executive officer.
Bacteria-resistant catheters to reduce infection
16 March, 2015Flinders University researchers are undertaking a project to reduce urinary tract infections associated with the use of catheters during hospital stays.
Prototype medical device to improve spinal surgery
10 March, 2015Flinders University researchers are developing a surgical instrument that will enable bone graft delivery during minimally invasive spinal fusion procedures.
Enrolment hold for GI Dynamics ENDO Trial
06 March, 2015Shares in medical device company GI Dynamics (ASX:GID) dropped by over 50% after the US FDA placed an enrolment hold on one of its clinical trials, following four cases of infection among participants.
Novotech awarded CRO Best Practice Award
27 February, 2015Sydney-based contract research organisation (CRO) Novotech has been awarded the CRO Best Practice Award for the third time in recent years by Frost & Sullivan.
Australian Innovation System Report released
26 February, 2015Innovation is key for Australian businesses to remain competitive according to the latest Australian Innovation System Report, which has been released by the office of the Chief Economist and the Department of Industry and Science.
Phylogica lines up EU patent for Phylomer screening
25 February, 2015 by Dylan Bushell-EmblingPhylogica (ASX:PYC) has been issued a notice of allowance for an EU patent covering using its Phylomer peptide libraries for drug discovery screening.
